Folgen
Walther Haenseler
Walther Haenseler
Bestätigte E-Mail-Adresse bei medgen.uzh.ch - Startseite
Titel
Zitiert von
Zitiert von
Jahr
A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response
W Haenseler, SN Sansom, J Buchrieser, SE Newey, CS Moore, ...
Stem cell reports 8 (6), 1727-1742, 2017
4502017
CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
R Flynn, A Grundmann, P Renz, W Hänseler, WS James, SA Cowley, ...
Experimental hematology 43 (10), 838-848. e3, 2015
1612015
Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
F Zambon, M Cherubini, HJR Fernandes, C Lang, BJ Ryan, V Volpato, ...
Human Molecular Genetics 28 (12), 2001-2013, 2019
1352019
Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
W Haenseler, F Zambon, H Lee, J Vowles, F Rinaldi, G Duggal, ...
Scientific reports 7 (1), 9003, 2017
982017
LRRK2 is recruited to phagosomes and co-recruits RAB8 and RAB10 in human pluripotent stem cell-derived macrophages
H Lee, R Flynn, I Sharma, E Haberman, PJ Carling, FJ Nicholls, ...
Stem Cell Reports 14 (5), 940-955, 2020
782020
Concise review: modeling neurodegenerative diseases with human pluripotent stem cell-derived microglia
W Haenseler, L Rajendran
Stem Cells 37 (6), 724-730, 2019
462019
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy
C Brendel, W Hänseler, V Wohlgensinger, M Bianchi, S Tokmak, ...
Human gene therapy methods 24 (3), 151-159, 2013
262013
Lentiviral gene therapy vector with UCOE stably restores function in iPSC-derived neutrophils of a CGD patient
W Haenseler, E Kuzmenko, A Smalls-Mantey, C Browne, R Seger, ...
Matters 2018, 2018
72018
Human induced pluripotent stem cell-derived vessels as dynamic atherosclerosis model on a chip
A Mallone, C Gericke, V Hosseini, K Chahbi, W Haenseler, MY Emmert, ...
52020
Systematic identification of structure-specific protein–protein interactions
A Holfeld, D Schuster, F Sesterhenn, P Stalder, W Haenseler, ...
bioRxiv, 2023.02. 01.522707, 2023
32023
An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ
P Stalder, T Serdiuk, D Ghosh, Y Fleischmann, L Malinovska, ...
bioRxiv, 2023.12. 18.572111, 2023
2023
Treatment of chronic granulomatous disease
WU Siler, J Reichenbach, W Hänseler
US Patent App. 17/765,172, 2022
2022
Human induced pluripotent stem cell-derived arteries as personalized models of atherosclerosis on-a-chip
A Mallone, C Gericke, V Hosseini, V Vogel, K Chahbi, JH Walther, ...
bioRxiv, 2020
2020
S3‐02‐03: Modelling Microglia with Human Pluripotent Stem Cells
SA Cowley, W Haenseler
Alzheimer's & Dementia 12, P268-P268, 2016
2016
Lentiviral SIN-vector for p47phox-deficient Chronic Granulomatous Disease Gene Therapy
R Valencia, D Wrona, C Brendel, W Haenseler, G Santilli, A Thrasher, ...
HUMAN GENE THERAPY 26 (10), A61-A62, 2015
2015
CRISPR-mediated Genotypic and Phenotypic Correction of a Chronic Granulomatous Disease
R Flynn, A Grundmann, P Renz, W Haenseler, WS James, SA Cowley, ...
2015
Lentiviral vector for p47phox gene therapy
W Haenseler, C Brendel, G Santili, W James, S Cowley, A Thrasher, ...
2013
Prevention of silencing by UCOE deletion constructs
W Haenseler, C Brendel, G Santili, W James, S Cowley, A Thrasher, ...
2012
HUMAN MIR223 PROMOTER AS NOVEL MYELOSPECIFIC PROMOTER FOR CGD GENE THERAPY
C Brendel, W Haenseler, V Wohlgensinger, M Bianchi, E Kouzmenco, ...
JOURNAL OF CLINICAL IMMUNOLOGY 32, 133-133, 2012
2012
Development of a Silencing Resistant Myelospecific Next Generation Gene Therapy Vector for Gene Therapy of the P47phox-deficient Form of Chronic Granulomatous Disease
W Hänseler
2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20